
Axial


Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases Our founders’ groundbreaking discoveries in RNA interference offer a powerful therapeutic approach to halt diseases at their source
From the Nobel prize to innovative medicines: Learn about RNA interference Halting Huntington’s disease at its source using gene silencing What is branched siRNA? Explore our unique approach see all press releases Atalanta Therapeutics Appoints Alfred Sandrock to Board of Directors
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Atalanta Therapeutics.
Similar listings buyers compare against this one.

Axial

Digital Ventures

Operator Collective

Zoovu

AIM Group

500 Global
Everything here links back to the same verified catalogue. Pick your next stop.